Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

À¯¹æ¼ö¾ç¾ÏÀÇ ÀÓ»ó ¹× º´¸®ÇÐÀû °íÂû A Clinicopathologic Analysis of Medullary Breast Cancer

´ëÇѾÏÇÐȸÁö 1997³â 29±Ç 3È£ p.422 ~ 428
¼Ò¼Ó »ó¼¼Á¤º¸
Àå¸íö/Myung Chul Chang ±èÁö¼ö/À±ÀÍÁø/³ëµ¿¿µ/À±¿©±Ô/¿À½Â±Ù/ÃÖ±¹Áø/¹ÚÀξÖ/Jee Soo Kim/Ik Jin Yun/Dong Young Noh/Yeo Kyu Youn/Seung Keun Oh/Kuk Jin Choe/In Ae Park

Abstract

¼­·Ð
À¯¹æ¾ÏÀº Çѱ¹ ¿©¼º¿¡ ¹ß»ýÇÏ´Â ¾ÏÁß 3À§¸¦ Â÷ÁöÇϸç, ÇöÀç ±× ¹ßº´À²ÀÌ Áõ°¡ÇÏ´Â Ãß¼¼·Î
±ÙÄ¡ ÀýÁ¦¼ú°ú ÇÔ²² ¹Ì¿ëÀû ¼ö¼ú¹æ¹ý°ú º¸Á¶Àû Ä¡·áÀÇ ¹ß´Þ·Î ÁÁÀº Ä¡·á¼ºÀûÀ» º¸ÀÌ°í ÀÖ
´Ù. À¯¹æ ¼ö¾ç ¾ÏÀº ħÀ±¼º À¯¹æ¾ÏÀÇ ÀÏÁ¾À¸·Î ´Ù¸¥ À¯¹æ¾Ï¿¡ ºñÇØ ¿¹ÈÄ°¡ ÁÁÀº ¾ÏÀ¸·Î ¾Ë
·ÁÁ® ¿ÔÁö¸¸ º´¸®Á¶Á÷ÇÐÀû Áø´Ü±âÁØÀÌ ¸ðÈ£ÇÏ¿© ¹®Á¦Á¡À¸·Î ÁöÀûµÇ¾î ¿Ô´Ù. 1977³â Ridolfi
µîÀº À¯¹æ ¼ö¾ç¾ÏÀÇ Á¤È®ÇÑ º´¸®Á¶Á÷ÇÐÀû Áø´Ü±âÁØÀ» Á¤ÀÇÇÏ°í ÀÌ¿¡ µû¶ó ÀüÇüÀû ¼ö¾ç¾Ï
(typical medullary cancer), ºñÀüÇüÀû ¼ö¾ç¾Ï(atypical medullary cancer)°ú ºñ¼ö¾ç¾Ï
(nonmedullary cancer)À¸·Î ºÐ·ùÇÏ¿´À¸¸ç ÀüÇüÀû ¼ö¾ç¾ÏÀÌ ¿¹ÈÄ°¡ ÁÁ´Ù°í ¹ßÇ¥ÇÏ¿´´Ù. ÀÌ¿¡
µû¶ó ÀúÀÚµéÀº À¯¹æ ¼ö¾ç¾ÏÀÇ º´¸®Á¶Á÷ÇÐ ¹× ÀÓ»óÀû Ư¡À» ¾Ë¾Æº¸±â À§ÇØ º» ¿¬±¸¸¦ ½ÃÇà
ÇÏ¿´´Ù.

Purpose : Medullary carcinoma of breast was known to have a better prognosis than
other breast cancer, but the histopathological definition of medullary carcinoma has
varied with time. This study was performed to clarify the clinicopathologic features of
medullary breast.
Materials and Methods : Twenty cases of breast cancer originally were diagnosed as
medullary carcinoma at the Department of Surgery, Seoul National University Hospital
from Jan. 1985 to Jun. 1995. The whole cases were reviewed and reclassified using the
strictly defined histologic criteria applied by Ridolfi et al.
Results : When reclassified, 16 tumors fulfilled the criteria of typical medullary cancer,
But the rest 4 tumors were found to be nonmedullary cancer. The patients ranged from
29 to 69 years in age with an average of 49. The main symptom was the painless
mass. The diameter of the tumor ranged from 1 to 8 cm with a mean size of 2.7 cm.
The axillary lymph node was positive in three cases. The estrogen receptor was
positive in 10%, and the progesterone receptor was positive in 20% of the cases. There
were no local recurrences or distant metastasis during a mean follow-up period of 5.5
years. All patients Survived until the last follow-up.
Conclusion : Medullary breast cancer has good prognosis but strict, uniform
histopathological diagnostic criteria are needed.

Å°¿öµå

Medullary breast cancer;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS